C3is Financials
This page shows C3is (CISS) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 3 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Cash generation, not reported earnings, drove the year, giving C3is room for deleveraging despite still-tight liquidity.
The clearest split is between accounting profit and cash conversion: operating cash flow was$25.0M while net income was-$2.7M , so the reported loss did not describe the cash engine of the business. Free cash flow of$23.4M also exceeded the year's financing outflow of-$19.7M , which helps explain why leverage eased without needing new external funding and why the balance sheet finished on firmer footing.
Top-line growth came with weaker operating efficiency: operating margin narrowed to
Balance-sheet repair was meaningful but not complete: debt-to-equity fell to 0.4x from 0.7x, and total liabilities dropped while cash rose. But the current ratio remained below 1.0x, so short-term claims still outweigh near-term resources even after a very cash-generative year.
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of C3is's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
C3is has an operating margin of 3.9%, meaning the company retains $4 of operating profit per $100 of revenue. This results in a moderate score of 59/100, indicating healthy but not exceptional operating efficiency. This is down from 23.8% the prior year.
C3is's revenue declined 17.8% year-over-year, from $42.3M to $34.8M. This contraction results in a growth score of 50/100.
C3is carries a low D/E ratio of 0.04, meaning only $0.04 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
With a current ratio of 6.21, C3is holds $6.21 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 100/100.
C3is converts 11.1% of revenue into free cash flow ($3.8M). This strong cash generation earns a score of 83/100.
C3is generates a 11.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 28/100. This is up from -3.9% the prior year.
C3is scores 0.92, below the 1.81 distress threshold. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
C3is passes 4 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, C3is generates $0.38 in operating cash flow ($4.0M OCF vs $10.5M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.
C3is earns $162.5 in operating income for every $1 of interest expense ($1.4M vs $8K). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
C3is generated $34.8M in revenue in fiscal year 2025. This represents a decrease of 17.8% from the prior year.
C3is's EBITDA was $7.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 51.6% from the prior year.
C3is reported $10.5M in net income in fiscal year 2025. This represents an increase of 481.1% from the prior year.
C3is earned $3.98 per diluted share (EPS) in fiscal year 2025. This represents an increase of 101.1% from the prior year.
Cash & Balance Sheet
C3is generated $3.8M in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 83.6% from the prior year.
C3is held $617K in cash against $0 in long-term debt as of fiscal year 2025.
C3is had 659,668 shares outstanding in fiscal year 2025. This represents an increase of 1767.5% from the prior year.
Margins & Returns
C3is's operating margin was 3.9% in fiscal year 2025, reflecting core business profitability. This is down 19.9 percentage points from the prior year.
C3is's net profit margin was 30.1% in fiscal year 2025, showing the share of revenue converted to profit. This is up 36.6 percentage points from the prior year.
C3is's ROE was 11.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 14.9 percentage points from the prior year.
Capital Allocation
C3is invested $162K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 90.0% from the prior year.
CISS Income Statement
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q4'22 |
|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | N/A | N/A | N/A | N/A | N/A | N/A |
CISS Balance Sheet
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q4'22 |
|---|---|---|---|---|---|---|
| Total Assets | $98.5M+9.3% | $90.1M-10.3% | $100.5M-26.9% | $137.4M+43.9% | $95.5M+139.5% | $39.9M |
| Current Assets | $20.8M+126.4% | $9.2M-43.7% | $16.3M-67.3% | $50.0M+146.2% | $20.3M+1884.4% | $1.0M |
| Cash & Equivalents | $617K-8.8% | $676K-85.4% | $4.6M-85.6% | $32.3M+4548.0% | $695K | $0 |
| Inventory | $1.3M+14.9% | $1.1M+29.2% | $884K-20.3% | $1.1M+61.0% | $689K+316.1% | $166K |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $3.4M-78.2% | $15.5M-46.7% | $29.1M-59.0% | $71.1M+78.1% | $39.9M+4035.6% | $965K |
| Current Liabilities | $3.4M-41.2% | $5.7M-69.4% | $18.7M-67.0% | $56.6M+41.8% | $39.9M+4035.6% | $965K |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $95.1M+27.5% | $74.6M+4.5% | $71.4M+7.6% | $66.3M+19.4% | $55.5M+42.8% | $38.9M |
| Retained Earnings | $4.5M+589.7% | $650K+153.0% | $257K+109.0% | -$2.9M-134.3% | $8.3M | N/A |
CISS Cash Flow Statement
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q4'22 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Capital Expenditures | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Investing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Financing Cash Flow | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A |
CISS Financial Ratios
| Metric | Q4'25 | Q2'25 | Q4'24 | Q2'24 | Q4'23 | Q4'22 |
|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | 6.21+4.6 | 1.61+0.7 | 0.870.0 | 0.88+0.4 | 0.51-0.6 | 1.06 |
| Debt-to-Equity | 0.04-0.2 | 0.21-0.2 | 0.41-0.7 | 1.07+0.4 | 0.72+0.7 | 0.02 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
What is C3is's annual revenue?
C3is (CISS) reported $34.8M in total revenue for fiscal year 2025. This represents a -17.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is C3is's revenue growing?
C3is (CISS) revenue declined by 17.8% year-over-year, from $42.3M to $34.8M in fiscal year 2025.
Is C3is profitable?
Yes, C3is (CISS) reported a net income of $10.5M in fiscal year 2025, with a net profit margin of 30.1%.
What is C3is's EBITDA?
C3is (CISS) had EBITDA of $7.9M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
What is C3is's operating margin?
C3is (CISS) had an operating margin of 3.9% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is C3is's net profit margin?
C3is (CISS) had a net profit margin of 30.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is C3is's return on equity (ROE)?
C3is (CISS) has a return on equity of 11.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is C3is's free cash flow?
C3is (CISS) generated $3.8M in free cash flow during fiscal year 2025. This represents a -83.6% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is C3is's operating cash flow?
C3is (CISS) generated $4.0M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are C3is's total assets?
C3is (CISS) had $98.5M in total assets as of fiscal year 2025, including both current and long-term assets.
What are C3is's capital expenditures?
C3is (CISS) invested $162K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is C3is's current ratio?
C3is (CISS) had a current ratio of 6.21 as of fiscal year 2025, which is generally considered healthy.
What is C3is's debt-to-equity ratio?
C3is (CISS) had a debt-to-equity ratio of 0.04 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is C3is's return on assets (ROA)?
C3is (CISS) had a return on assets of 10.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is C3is's Altman Z-Score?
C3is (CISS) has an Altman Z-Score of 0.92, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is C3is's Piotroski F-Score?
C3is (CISS) has a Piotroski F-Score of 4 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are C3is's earnings high quality?
C3is (CISS) has an earnings quality ratio of 0.38x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can C3is cover its interest payments?
C3is (CISS) has an interest coverage ratio of 162.5x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is C3is?
C3is (CISS) scores 70 out of 100 on our Financial Profile, indicating strong overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.